Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ BioSpace Nawigacja wpisu Profluent, Lilly partner in genetic medicine deal worth up to $2.25 billion – Reuters GSK Earnings Boosted by Higher Specialty Medicine Sales – WSJ
